留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

放射治疗新技术对局部晚期宫颈癌治疗的影响

孟庆宇 张福泉

孟庆宇, 张福泉. 放射治疗新技术对局部晚期宫颈癌治疗的影响[J]. 协和医学杂志, 2013, 4(4): 433-437. doi: 10.3969/j.issn.1674-9081.2013.04.018
引用本文: 孟庆宇, 张福泉. 放射治疗新技术对局部晚期宫颈癌治疗的影响[J]. 协和医学杂志, 2013, 4(4): 433-437. doi: 10.3969/j.issn.1674-9081.2013.04.018

放射治疗新技术对局部晚期宫颈癌治疗的影响

doi: 10.3969/j.issn.1674-9081.2013.04.018
详细信息
    通讯作者:

    张福泉 电话:010-69155485, E-mail:zhangfuquan3@sina.com

  • 中图分类号: R711.74

  • [1] Jemal A, Bray F, Center MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61:69-90. doi:  10.3322/caac.20107
    [2] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Cervical cancer. NCCN Guidelines Version 1.2012[S/OL].[2013-08-05].http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.
    [3] Perez CA, Camel HM, Kuske RR, et al.Radiation therapy alone in the treatment of carcinoma of the uterine cervix:a 20-year experience[J].Gynecol Oncol, 1986, 23:127-140. doi:  10.1016/0090-8258(86)90216-7
    [4] Beriwal S, Gan GN, Heron DE, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2007, 68:166-171. doi:  10.1016/j.ijrobp.2006.12.023
    [5] Chen CC, Lin JC, Jan JS, et al. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer[J]. Gynecol Oncol, 2011, 122:9-13. doi:  10.1016/j.ygyno.2011.03.034
    [6] King M, McConkey C, Latief TN, et al.Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects[J].Clin Oncol (R Coll Radiol), 2006, 18:38-45. doi:  10.1016/j.clon.2005.09.001
    [7] Novetsky AP, Einstein MH, Goldberg GL, et al.Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer[J].Gynecol Oncol, 2007, 105:635-640. doi:  10.1016/j.ygyno.2007.01.032
    [8] Saibishkumar EP, Patel FD, Sharma SC.Results of radiotherapy alone in the treatment of carcinoma of uterine cervix:a retrospective analysis of 1069 patients[J].Int J Gynecol Cancer, 2005, 15:890-897. doi:  10.1111/j.1525-1438.2005.00250.x
    [9] Perez CA, Grigsby PW, Lockett MA, et al. Radiation therapy morbidity in carcinoma of the uterine cervix:dosimetric and clinical correlation[J].Int J Radiat Oncol Biol Phys, 1999, 44:855-866. doi:  10.1016/S0360-3016(99)00111-X
    [10] Pourquier H, Dubois JB, Delard R.Radiation therapy of cervical cancer with dosimetric prevention of late pelvic complications[J]. Bull Cancer Radiother, 1996, 83:135-143. doi:  10.1016/0924-4212(96)81745-2
    [11] Gandhi AK, Sharma DN, Rath GK, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma:a prospective randomized study[J]. Int J Radiat OncolBiol Phys, 2013, 87:542-548. doi:  10.1016/j.ijrobp.2013.06.2059
    [12] Chan P, Dinniwell R, Haider MA, et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy:a cinematic-MRI point-of-interest study[J]. Int J Radiat Oncol Biol Phys, 2008, 70:1507-1515. doi:  10.1016/j.ijrobp.2007.08.055
    [13] van de Bunt L, van der Heide UA, Ketelaars M, et al. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer:The impact of tumor regression[J].Int J Radiat Oncol Biol Phys, 2006, 64:189-196. doi:  10.1016/j.ijrobp.2005.04.025
    [14] Taylor A, Powell MEB. An assessment of interfractional uterine and cervical motion:implications for radiotherapy target volume definition in gynecological cancer[J]. Radiother Oncol, 2008, 88:250-257. doi:  10.1016/j.radonc.2008.04.016
    [15] Nickers P, LeTinier F, Alt M, et al. Tomotherapy of locally advanced cervix carcinoma:clinical validation of 3 mm CTV-PTV expansion[J]. Int J Radiat Oncol Biol Phys Supplement, 2012, 84:S439-S440. doi:  10.1016/s0167-8140(12)70733-8
    [16] 庞皓文, 邱杰, 孙帅, 等.宫颈癌调强放疗中直肠体积与位置变化及对吸收剂量影响[J].中华肿瘤放射学杂志, 2012, 21:258-261. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfszl201203019
    [17] 庞皓文, 邱杰, 全红, 等.宫颈癌调强放疗中膀胱解剖结构变化及对其吸收剂量影响研究[J].中华肿瘤放射学杂志, 2011, 20:218-221. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfszl201103014
    [18] Khan A, Jensen LG, Sun S, et al. Optimized planning target volume for intact cervical cancer[J].Int J Radiat Oncol Biol Phys, 2012, 83:1500-1505. doi:  10.1016/j.ijrobp.2011.10.027
    [19] Pötter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer[J].Radiother Oncol, 2007, 83:148-155. doi:  10.1016/j.radonc.2007.04.012
    [20] Dimopoulos JC, Lang S, Kirisits C, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy[J].Int J Radiat Oncol Biol Phys, 2009, 75:56-63. doi:  10.1016/j.ijrobp.2008.10.033
    [21] Simpson D, Yashar CM, Kannan N, et al. CT and MRI-based image guided brachytherapy for cervical cancer:a multi-institutional report[J]. Int J Radiat Oncol Biol Phys, 2012, 84:S19. http://www.sciencedirect.com/science/article/pii/S0360301612009972
  • 加载中
计量
  • 文章访问数:  174
  • HTML全文浏览量:  62
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-09-08
  • 刊出日期:  2013-10-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!